The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Side Effects and Photosensitization of Human Tissues after Aminolevulinic Acid
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy
Loh, C., MacRobert, A., Bedwell, J., Regula, J., Krasner, N., & Bown, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.284 · Cited by 263
Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid
Grant, W. E., MacRobert, A., Bown, S. G., Hopper, C., & Speight, P. M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91347-o · Cited by 263
Bedwell, J., MacRobert, A., Phillips, D., & Bown, S. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.175 · Cited by 253
Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats
Van Hillegersberg, R., Van Den Berg, J. W. O., Kort, W. J., Terpstra, O. T., & Wilson, J. H. P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90860-2 · Cited by 198
DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
Peng, Q., Warloe, T., Moan, J., Heyerdahl, H., Steen, H. B., Nesland, J. M., & Giercksky, K. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb09154.x · Cited by 178
Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase
Dailey, H. A., & Smith, A. (1984) · Biochemical Journal · doi:10.1042/bj2230441 · Cited by 140
The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N
Berlin, N. I., Neuberger, A., & Scott, J. J. (1956) · Biochemical Journal · doi:10.1042/bj0640080 · Cited by 126
Cited by
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., & Peng, Q. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.889 · Cited by 4,716
Self-citationStummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423
In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications
Wagnieres, G. A., Star, W. M., & Wilson, B. C. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb02521.x · Cited by 942
Stummer, W., Novotny, A., Stepp, H., Goetz, C., Bise, K., & Reulen, H. J. (2000) · Journal of Neurosurgery · doi:10.3171/jns.2000.93.6.1003 · Cited by 881
Photodynamic therapy in dermatology
Kalka, K., Merk, H., & Mukhtar, H. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90209-3 · Cited by 522
5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas
Mahmoudi, K., Garvey, K. L., Bouras, A., Cramer, G., Stepp, H., Jesu Raj, J. G., Bozec, D., Busch, T. M., & Hadjipanayis, C. G. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03103-4 · Cited by 292
Uehlinger, P., Zellweger, M., Wagnières, G., Juillerat-Jeanneret, L., van den Bergh, H., & Lange, N. (2000) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(99)00159-1 · Cited by 221
Wiegell, S. R. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.9.1173 · Cited by 142
“The advantage of using ALA is that PpIX and other intermediate photosensitizers are rapidly eliminated from the body, limiting the skin photosensitization to a few days after oral use, whereas topical ALA does not cause any generalized photosensitivity.(2) ALA-PDT can induce erythema and hyperpigmentation of the treat…”
BackgroundHinnen, P., de Rooij, F., van Velthuysen, M., Edixhoven, A., van Hillegersberg, R., Tilanus, H., Wilson, J., & Siersema, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.559 · Cited by 130
Suero Molina, E., Black, D., Kaneko, S., Müther, M., & Stummer, W. (2022) · Journal of Neurosurgery · doi:10.3171/2021.12.jns211724 · Cited by 28
Metadata
- Authors
- Webber, J., Kessel, D., & Fromm, D.
- Venue
- Journal of Surgical Research
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 68
- Issue
- 1
- Pages
- 31-37
- ISSN
- 0022-4804 (ISSN-L)
- OpenAlex
- W2008613456
- Cited by
- 189
- References
- 7
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.